雷宁-血管酶系统抑制对腹膜透析中的残留功能的影响
Jing Xin Goh1, Kamal Sud2,3, Katrina Chau4,5
1School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.
Medicina (Kaunas, Lithuania)
|February 27, 2026
概括
列宁- ангиотензин系统抑制剂 (RASI) 在腹膜透析 (PD) 患者中没有显著地保持功能 (RKF). 这项研究没有发现RASI对这一群体的RKF下降有意义的益处.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 列宁- ангиотензин系统抑制剂 (RASI) 建议在腹腔透析 (PD) 患者中保留残留功能 (RKF).
- 目前关于RASI在PD期间维持RKF的疗效的证据是不一致的.
- 这项研究调查了RASI使用对PD患者RKF衰减的影响.
研究的目的:
- 评估氨酸 - ангиотензин系统抑制剂 (RASI) 对腹透析 (PD) 患者残留功能 (RKF) 衰退的影响.
- 评估RASI治疗是否影响PD患者的尿量和残留Kt/V轨迹.
- 确定RASI使用与住院治疗或PD相关感染率之间的关联.
主要方法:
- 在一个大都市透析中心对231名腹透析 (PD) 患者进行了回顾性队列研究.
- 通过残留Kt/V和尿量评估残留功能 (RKF);RASI暴露以时间依赖变量为模型.
- 线性混合效应模型用于分析时间,RASI使用和其他共变量对RKF结果的影响.
主要成果:
- 没有观察到RASI暴露对尿液体积轨迹的显著影响.
- 随着RASI的使用,剩余Kt/V的边界下降速度较慢 (相互作用β = +0.038,p = 0.069).
- 在RASI使用者和非使用者之间,住院和PD相关感染率相似.
结论:
- 在这组腹腔透析 (PD) 患者中,素-血管激素系统抑制剂 (RASI) 治疗与剩余功能 (RKF) 的有意义的保存无关.
- 这些发现与最近的证据一致,这些证据表明RASI在PD期间维持RKF时具有混合的有效性.
- 需要进行更大规模的前性试验,以确定RASI在保护RKF和改善PD患者长期治疗结果方面的作用.
相关概念视频
Antihypertensive Drugs: Direct Renin Inhibitors
1.6K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
1.3K
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.7K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.7K
Heart Failure Drugs: Diuretics
1.1K
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
1.1K
Acute Kidney Injury V: Interprofessional Care
407
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
407
Dialysis
1.7K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.7K


